In other solid tumors, such as ovarian and colon cancers, CCL19-expressing embryonic endothelial progenitor cells and mesenchymal stem cells functioned to activate the local TIME and led to a good therapeutic effect [24, 25]. This evidence concerns the gene CCL19 and colonic neoplasm.